Capital Research Global Investors Has $659.09 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Capital Research Global Investors trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.0% in the fourth quarter, Holdings Channel reports. The fund owned 1,163,737 shares of the medical equipment provider’s stock after selling 388,935 shares during the quarter. Capital Research Global Investors’ holdings in Intuitive Surgical were worth $659,094,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of ISRG. Holos Integrated Wealth LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $25,000. Newbridge Financial Services Group Inc. lifted its stake in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 33 shares during the last quarter. Olistico Wealth LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Caitlin John LLC bought a new position in shares of Intuitive Surgical in the 3rd quarter valued at $30,000. Finally, Laurel Wealth Advisors LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $31,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $422.06 on Monday. The firm has a market cap of $149.48 billion, a P/E ratio of 51.16, a P/E/G ratio of 3.37 and a beta of 1.46. Intuitive Surgical, Inc. has a 12-month low of $396.68 and a 12-month high of $603.88. The business has a fifty day simple moving average of $447.24 and a 200 day simple moving average of $500.70.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same period last year, the company earned $1.81 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the transaction, the director directly owned 239 shares of the company’s stock, valued at $113,156.94. This trade represents a 67.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president directly owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 6,803 shares of company stock valued at $2,911,573 in the last quarter. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

ISRG has been the subject of a number of research reports. Robert W. Baird increased their price target on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. dropped their price target on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Piper Sandler reiterated an “overweight” rating and issued a $580.00 price target on shares of Intuitive Surgical in a research note on Tuesday, June 2nd. The Goldman Sachs Group set a $558.00 price target on Intuitive Surgical in a research note on Wednesday, May 27th. Finally, TD Cowen dropped their price target on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $573.63.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.